MODD Modular Medical, Inc.

BEARISH Impact: 7/10 424B4
Horizon months Filed Mar 4, 2026 Processed 3mo ago SEC 0001213900-26-023516
Prospectus supplement
Final — all horizons settled through T+60d ⚠ clustered
MODD ▼ -9.82% at T+60d
SHORT call ✓ call won +9.82% · α vs SPY +19.91% · entry $5.70 → $5.14
Last close $4.86 (close Jun 8) · +14.74% from $5.70 entry (call sign-flipped)
Entry anchored
Mar 4, 11:53 AM ET
via Databento tick
T+1d
+5.79%
call -5.79% · α -6.36%
$6.03
settled 3mo ago
T+5d
+15.79%
call -15.79% · α -17.12%
$6.60
settled 3mo ago
T+20d
-5.61%
call +5.61% · α +1.20%
$5.38
settled 2mo ago
T+60d
-9.82%
call +9.82% · α +19.91%
$5.14
settled 12d ago

Executive Summary

Modular Medical (MODD) has priced a $12M best-efforts offering of 68.1M shares and warrants at $0.1762 per share, representing a 12% discount to the prior closing price. The proceeds will be used to repay a $250K CEO loan and fund operations through FDA approval of its Pivot insulin pump, but the company faces a going concern risk with only $2.9M in cash and a history of significant losses.

Actionable Insight

Monitor FDA approval timeline for Pivot insulin pump and subsequent capital raises, as current cash may not be sufficient to reach commercialization

Key Facts

  • Offering of 68,098,000 shares and warrants priced at $0.1762 per share, raising $11.15M in gross proceeds before expenses
  • Offering price represents a 12% discount to the prior closing price of $0.1570
  • Dilution of 87% based on 77.7M shares outstanding pre-offering and 145.8M shares post-offering
  • Proceeds to be used to repay $250K CEO loan and fund operations through FDA approval of Pivot insulin pump
  • Company has $2.9M in cash and faces going concern risk with no revenue and $21.9M net loss in 9 months
  • No minimum offering requirement, increasing risk that insufficient capital will be raised

Financial Impact

Raises $11.15M in gross proceeds, increases share count by 87% from 77.7M to 145.8M, diluting existing shareholders

dilutioncashFlowmarketCap

Risk Factors

  • Going concern risk due to limited cash and history of losses
  • Significant dilution from offering
  • No minimum offering requirement increases funding risk
  • FDA approval timeline uncertainty

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001213900-26-023516
Document: 0001213900-26-023516-index-headers.html0001213900-26-023516
Document: 0001213900-26-023516-index.html0001213900-26-023516
Document: 0001213900-26-023516.txt0001213900-26-023516
7 reports for MODD
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+1▲ +36.44%Feb 27, 2026
Filters
Rows
Reports for MODD — sortable, filterable
Type Now
Apr 23, 2026
6w ago
S-3
BEARISH ★ 6/10
$4.65 $3.95▲ +14.96%▲ +19.60%$4.86 (−4.63%)
Apr 21, 2026
7w ago
8-K
BEARISH ★ 7/10
$5.00 $3.36▲ +32.80%▲ +37.72%$4.86 (+2.80%)
Apr 21, 2026
7w ago
424B5
BEARISH ★ 7/10
$5.00 $3.36▲ +32.80%▲ +37.72%$4.86 (+2.80%)
Apr 16, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$4.82 $3.30▼ −31.54%▼ −37.35%$4.86 (+0.83%)
Mar 4, 2026
13w ago
424B4
BEARISH ★ 7/10
$5.70 $5.38▲ +5.61%▲ +1.20%$4.86 (+14.74%)
Mar 4, 2026
14w ago
EFFECT
NEUTRAL ★ 5/10
$5.70 $5.38▼ −5.61%▼ −1.20%$4.86 (−14.74%)
Feb 27, 2026
14w ago
S-1
BEARISH ★ 7/10
$7.41 $4.71▲ +36.44%▲ +28.88%$4.86 (+34.41%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 5h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access